tiprankstipranks
Advertisement
Advertisement
Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
PremiumRatingsInventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
2M ago
Inventiva initiated with an Overweight at Barclays
Premium
The Fly
Inventiva initiated with an Overweight at Barclays
3M ago
Inventiva initiated with an Outperform at Leerink
Premium
The Fly
Inventiva initiated with an Outperform at Leerink
3M ago
Inventiva 32.47M share Spot Secondary priced at $3.85
PremiumThe FlyInventiva 32.47M share Spot Secondary priced at $3.85
5M ago
Inventiva announves $125M American Depositary shares offering
Premium
The Fly
Inventiva announves $125M American Depositary shares offering
5M ago
Wolfe starts Inventiva at Outperform on ‘constructive’ lanifibranor view
Premium
The Fly
Wolfe starts Inventiva at Outperform on ‘constructive’ lanifibranor view
5M ago
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
PremiumRatingsBuy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
6M ago
Inventiva price target raised to $24 from $20 at H.C. Wainwright
Premium
The Fly
Inventiva price target raised to $24 from $20 at H.C. Wainwright
6M ago
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
Premium
Ratings
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100